no longer exhibited a significant increase in R rs (2.8 ± 0.5 cm H 2 O/ml · s) after caffeine. C rs did not differ significantly between groups, although radial alveolar counts were lower in both groups of LPS-exposed pups. Conclusions: Caffeine promotes anti-inflammatory effects in the immature lung of prenatal LPS-exposed rat pups associated with improvement of R rs , suggesting a protective effect of caffeine on respiratory function via an anti-inflammatory mechanism.
Introduction
Bronchopulmonary dysplasia (BPD) is the most prevalent chronic lung disease secondary to preterm birth and a major cause of morbidity. Inflammation, cellular-endothelial interaction, chemotaxis of neutrophils, increased pro-inflammatory cytokines, proteolytic and oxidative damage, increased alveolar-capillary permeability and tissue remodeling involving fibrosis and vessel growth are all considered to be involved in the pathogenesis of BPD [1] . These inflammatory mechanisms that have important roles in the pathogenesis of BPD may result from chorioamnionitis in the antenatal period with superimposed mechanical ventilation, oxygen therapy, and noso-comial infections in the postnatal period [2] [3] [4] . In addition to amplifying the inflammatory response of the preterm lung to further interventions in the early neonatal period, chorioamnionitis and BPD both predispose to increased airway reactivity [4] [5] [6] .
The main interventions for preventing or ameliorating BPD comprise protecting previously injured lung from further injury and controlling the inflammatory process [7] . Caffeine has been widely used for apnea of prematurity and, apart from significantly decreasing the incidence of BPD, has significant beneficial effects on various neonatal morbidities [8] [9] [10] . Although the exact mechanism of lung-protective effects of caffeine has not yet been elucidated, it has been proposed that it is due to decreased need for mechanical ventilation by enhancing respiratory control [11] . Additionally, caffeine may also have anti-inflammatory effects, as recently reported in a model of hyperoxia-mediated pulmonary inflammation in rat pups [12] . We therefore sought to test the hypothesis that caffeine contributes to improved respiratory function via an anti-inflammatory effect in lungs of a lipopolysaccharide (LPS)-induced pro-inflammatory rat pup model of amnionitis.
Methods

Animal Model
Experiments were performed on timed-pregnancy SpragueDawley rats (Charles River Laboratories, Portage, Mich., USA). All experimental procedures were conducted in accordance with NIH guidelines and institutional approval. Maternal animals were anesthetized, and after exposing the rat uterus by laparotomy, LPS ( E. coli 055:B5; Sigma) or normal saline (NS) control solution was injected into each amniotic sac (1 μg/amniotic sac) on day 20 in a volume of 10 μl. After returning the uterus to the abdomen, animals recovered in individual cages under close observation. Pups were delivered spontaneously 2 days after LPS or NS injections. A total of 3-4 dams were employed per study protocol, and survival of pups was 75-90%, which did not differ between antenatal LPS or NS exposure. Caffeine base (10 mg/kg/day), or water placebo, was given orally for 14 days starting from postnatal day 1 (p1) to subgroups of pups exposed to LPS or NS ( fig. 1 ). Caffeine blood levels were obtained via cardiac puncture and evaluated by highperformance liquid chromatography at p2, p7 and p14 in an additional 4-5 pups at each age.
Cytokine Protein Measurements in Lung Tissue
Lung harvests from rat pups for cytokine analysis were performed after lethal injection. Lungs were homogenized in RIPA cell lysis buffer containing phenylmethylsulfonyl fluoride (2 m M ), and 1 μg/ml aprotinin, leupeptin, and pepstatin A and were centrifuged for 30 min at 12,000 g at 4 ° C. Supernatants were collected and stored at -80 ° C and total protein content was measured. LPSinduced cytokine protein level was measured by commercially available Milliplex rat cytokine panels using Luminex technology [13] at day 8 for three major pro-inflammatory cytokines: interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) (Millipore Corp., Temecula, Calif., USA) in response to antenatal LPS or NS exposure. Expression of IL-1β was additionally measured at days 8 and 14 in NS and LPS-exposed pups after oral caffeine or water placebo administration (n = 4, all groups). Quantification of relative cytokine expression for different age groups was normalized with BSA protein assay and expressed as pg of cytokine/μg of protein.
CD68 Immunohistochemistry
Following euthanasia at day 8, pups' lungs from four groups (NS, LPS, LPS+caffeine and NS+caffeine, n = 6-7, all groups) were perfused with PBS/heparin and then fixed in situ with 10% neutral buffered formalin solution. The fixed left lung tissue was embedded in paraffin wax after tissue processing, sectioned at 5 μm thickness and then processed for immunohistochemistry. The tissues were stained with rabbit polyclonal CD68 antibody (1: 200; Santa Cruz Biotechnology, Santa Cruz, Calif., USA) using a standard immunostaining protocol. Blinded inflammatory scoring was performed by counting positive CD68 cells in nine comparable nonoverlapping high-power fields from each animal.
Respiratory System Compliance and Resistance Measurements
Respiratory system compliance and resistance were measured in 8-day-old pups using a pneumotach and a custom-made headout plethysmography system. Data were obtained in the four groups of pups exposed to antenatal LPS or NS followed by postnatal caffeine or placebo (n > 8/group). Rat pups were anesthetized with an intraperitoneal injection of ketamine/xylazine (5 and 3 mg/100 g b.w.). A custom-made latex mask was sealed over the face of the rat, and the body was then placed inside a small plethysmograph with its head protruding into a separate compartment. A pneumotach (8430 Series; Hans Rudolph, Inc., Shawnee, Kans., USA) was attached to the mask for the measurement of airflow associated with breathing; a bias flow of 100% O 2 was also delivered to the mask, digitally converted (PowerLab 8/30; ADInstruments, Colorado Springs, Colo., USA) and electronically offset for integration of tidal volume. Rectal and chamber temperature were monitored and respiratory system compliance (C rs ) and resistance (R rs ) determined as described previously by ourselves [14] . Briefly, a vacuum applied to the body compartment enabled negative infla- 237 tion pressure (P I ) to be measured continuously. A small adjustable leak allowed fine control of individual P I s. During inflation the vacuum was then released at the occurrence of the first breath, resulting in a passive decay in lung volume. Using the inflation volume (V L ), C rs was calculated (C rs = V L /P I ). R rs was calculated by determining the time constant of the passive decay in lung volume (R rs = Τ rs /C rs ). One initial maneuver was performed to minimize lung hysteresis and the values for C rs and R rs were determined from the subsequent 3-4 consecutive inflations.
Lung Morphology 5-μm thick sections from the paraffin block of four groups (NS, LPS, LPS+caffeine and NS+caffeine, n = 6-7, all groups) of 8-dayold pups' lungs were cut and stained with hematoxylin and eosin for tissue morphology. Three sections from each pup were analyzed using research-based digital image analysis software (Imagepro Plus 7.0; Media Cybernetics, Silver Spring, Md., USA). The radial alveolar counts (RACs) were estimated by the method of Cooney and Thurlbeck [15] , and were performed by a technician unaware of the treatment groups.
Statistical Analysis
The effect of antenatal LPS versus NS on postnatal IL-1β, TNF-α, and IL-6 cytokine protein levels at day 8 was compared via unpaired t tests. All other comparisons were via one-way ANOVA with post hoc comparisons. Data are expressed as mean ± SEM.
Results
Caffeine Levels
We sought to ensure caffeine levels were comparable to therapeutic levels observed in neonates. Caffeine plasma levels were 13.74 ± 1.04, 9.31 ± 1.43, and 9.67 ± 1.50 μg/ml at p2, p7, and p14, respectively (n = 4-5/group).
Cytokine Protein Measurement and CD68 Counts in Lung Tissue
We initially sought to document an effect of prior LPS exposure on pro-inflammatory cytokine expression at day 8. IL-1β increased by 65% in LPS-exposed pups (0.049 ± 0.002 vs. 0.081 ± 0.004 pg/μg, p < 0.01, for NS vs. LPS, respectively, n = 4/group; fig. 2 a) . There was no effect of antenatal LPS on TNF-α (0.09 ± 0.04 vs. 0.08 ± 0.03 NS vs. LPS) or on IL-6 (0.13 ± 0.008 vs. 0.13 ± 0.01 pg/μg tissue, NS vs. LPS), n = 4, all groups. We therefore focused on the effect of postnatal caffeine on IL-1β expression. There was a significant effect of caffeine on IL-1β levels at day 8 which fell from 0.08 ± 0.004 to 0.06 ± 0.01 pg/μg, p < 0.05 in LPS-exposed pups ( fig. 2 a) . There was no effect of caffeine in NS-treated controls not exposed to LPS (n = 4, all groups). At day 14, IL-1β levels between groups no longer differed significantly (0.07 ± 0.01, 0.10 ± 0.01, 0.07 ± 0.01 and 0.09 ± 0.02 for NS control, LPS, LPS+caffeine, and NS control+caffeine groups, respectively, n = 4, all groups). At day 14, TNF-α and IL-6 levels also did not differ between groups.
As an additional pro-inflammatory marker, we employed CD68 counts which reflect macrophage activity. Intra-amniotic LPS exposure significantly increased CD68 counts (5.10 ± 0.62 vs. 7.80 ± 0.85 for NS controls vs. LPS-exposed, respectively, p < 0.05). In parallel to the IL-1β data, this increase in CD68 counts was no longer significant after caffeine treatment ( fig. 2 b) .
Respiratory System Compliance and Resistance Measurements
We then sought to correlate the decrease in IL-1β expression after caffeine exposure with an effect on respiratory system mechanics. As seen in figure 3 a, intra-amniotic LPS significantly increased R rs (4.7 ± 0.9 cm H 2 O/ ml · s) compared to NS (1.6 ± 0.3 cm H 2 O/ml · s) treated rats (n > 8/group; p < 0.05). R rs for intra-amniotic LPStreated rats was not different from NS rats following daily caffeine treatment (LPS+caffeine, 2.8 ± 0. IL-1β levels in pups of LPS and NS rats at day 8 with or without caffeine treatment ( a ). There was a significant increase in IL-1β after antenatal LPS exposure which decreased after postnatal caffeine treatment. Caffeine did not affect salineexposed control pups. Parallel data for CD68 counts in the same groups ( b ). The significant increase after antenatal LPS exposure was no longer observed after caffeine. Mean ± SEM ( * p < 0.05).
ml · s), indicating that caffeine prevented the LPS-induced increase in R rs . Caffeine had no effect on R rs in NS control pups ( fig. 3 b) . C rs was not significantly affected by LPS or caffeine exposure ( fig. 3 b) .
Lung Morphology
In order to assess alveolar morphology, RACs were assessed in four pup groups at day 8: NS, LPS-exposed, and LPS+caffeine, and NS+caffeine (n = 6-7/group). After antenatal LPS there was a significant decrease in RACs (8.44 ± 0.23 vs. 6.63 ± 0.31, p < 0.05 for NS controls vs. LPS-exposed, respectively). RACs in the LPS+caffeine pups were also lower when compared to the NS control pups (8.44 ± 0.23 vs. 7.23 ± 0.18 for NS controls and LPScaffeine, respectively, p < 0.05; fig. 4 ). 3 . R rs ( a ) and C rs ( b ) in 8-day-old rat pups with or without caffeine treatment following intra-amniotic LPS or NS. There was a significant ( * p < 0.05) increase in R rs after LPS exposure which was eliminated by caffeine treatment. In saline-exposed controls there was no effect of caffeine on R rs . There was no difference in C rs ( b ) between treatment groups. Mean ± SEM ( * p < 0.05). 
Discussion
We have shown that intra-amniotic LPS injection resulted in a marked increase in levels of IL-1β accompanied by inflammatory change in the lungs of the offspring at postnatal day 8. This was associated with an increase in R rs in LPS-exposed pups. These molecular and functional changes demonstrated in our pro-inflammatory model were both reversed by postnatal caffeine administration at plasma levels similar to therapeutic neonatal levels. We therefore speculate that caffeine may serve a protective effect on neonatal lung function via anti-inflammatory mechanisms.
To document a potential anti-inflammatory effect of caffeine therapy, we studied rat pups exposed to a proinflammatory intrauterine environment after intra-amniotic LPS (at the same dose employed by others [6] ) or saline and observed a high survival rate in the pups which did not differ between groups. Our initial observation that IL-1β is markedly elevated on postnatal day 8 after intrauterine LPS exposure caused us to focus on this proinflammatory. We did not observe a response of TNF-α or IL-6 to antenatal LPS in our model, however an elevation in those cytokines may have resolved by p8. Small group sizes may also have contributed to this observation as well as the failure of IL-1β levels to remain significantly elevated at p14. Future study, incorporating message and protein expression for a greater number of cytokines at different time points and in different models, should address this issue. Recent data, however, failed to show upregulation of IL-6 associated with inflammatory changes in bronchoalveolar lavage fluid of BPD infants [16] .
Xanthines are used extensively for apnea of prematurity, and in recent years caffeine became the focus of interest with the newly discovered protective effects for BPD and cerebral palsy at 18-21 months of age [9, 10] . This effect of caffeine on respiratory drive may result in less frequent intermittent hypoxic episodes and decrease oxidant stress which, in turn, may diminish inflammation [17] . However, a potential anti-inflammatory effect of caffeine has not been widely considered. Our current demonstration of a decrease in IL-1β protein expression after postnatal caffeine was limited to LPS-exposed pups. These data are supported by our additional observation that the increase in macrophage activity induced by LPS is no longer significant after caffeine exposure. We know of no comparable data in preterm infants relating the beneficial effect of caffeine to an upregulated pro-inflammatory environment.
Chorioamnionitis, preterm birth, and BPD are all well-recognized precursors of later airway reactivity [5] . Prior studies have exposed pregnant rats or mice to intraperitoneal LPS and observed postnatal inflammation implicated in delayed lung maturation [18, 19] . Choi et al. [6] did not observe an effect of intra-amniotic LPS on airway function in 14-day-old rat pups in the absence of postnatal hyperoxia. In contrast, Velten et al. [19] observed a significant increase in pulmonary resistance and a non-significant decrease in compliance in 14-day-old mouse pups exposed to antenatal LPS and postnatal room air. Their findings are consistent with our respiratory mechanics data, and suggest a unique vulnerability of the immature airways to perinatal inflammation.
RACs are a widely used measure of alveolar morphology [15] and were decreased after LPS exposure. There appeared to be a corresponding decrease in C rs after LPS, although this was not significant. Caffeine did not significantly improve alveolar morphology or C rs after LPS exposure, in contrast to the significant increase in R rs after LPS which was no longer observed after caffeine. These data suggest that the effect of caffeine is not primarily on alveolar morphology as demonstrated by our C rs and RAC data, but rather on the R rs of LPS-exposed pups. We do acknowledge that while caffeine-treated LPS-exposed pups no longer differed from controls, there was no significant difference between the 2 LPS-exposed pups. Future study of inflammatory markers should therefore focus on airway-related structures and a possible anti-inflammatory effect of caffeine at this site, although beyond the scope of this study. We also acknowledge that future experiments should incorporate IL-1β blockade to clearly document a causal relationship between caffeine treatment and improved respiratory function.
Caffeine acts as a non-specific antagonist of adenosine receptors. However, there is no clear consensus on the mechanisms whereby xanthines might influence inflammation. In contrast to our findings, a protective effect of adenosine A 2 receptor agonist has been observed in a mature rat lung injury model [20] . Li et al. [21] showed that chronic caffeine treatment at low dose and acute caffeine treatment at high dose attenuated lung damage and cytokine response in a mature mouse lung injury model, whereas acute caffeine treatment at low dose enhanced lung damage. Their data illustrate the impact of caffeine dose on anti-inflammatory effects, and that this might be independent of A 2A receptors.
An anti-inflammatory effect of caffeine in newborns has been suggested, via A 1 receptor blockade that inhibits pretranscriptional TNF-α production by cord blood monocytes [22] . Cytokine profiles have been measured in preterm infants and correlated with serum caffeine levels. Plasma IL-1β levels were not clearly influenced by serum caffeine levels, although a pro-inflammatory profile was observed at caffeine levels >20 μg/ml [23] . Recent data employing a neonatal rat pup have shown that in a model of hyperoxic lung injury, caffeine therapy reduced cellular and biochemical markers of pulmonary inflammation [12] . Clearly there is need for further investigation to evaluate the relative roles of adenosine receptor subtype, maturation and caffeine concentration in any anti-inflammatory effects of xanthine therapy in human infants.
In summary, we have provided evidence in a neonatal rat pup model that plasma concentrations of caffeine exert an anti-inflammatory effect that is associated with improvement in respiratory mechanics. Benefit was limited to rat pups exposed to a pro-inflammatory intrauterine environment. It is tempting to speculate that the beneficial effect of caffeine in preterm infants might be enhanced in the presence of chorioamnionitis, a known precipitant of preterm birth and longer term neonatal morbidity.
